Work

PI3K/AKT/mTOR genomic alterations in 94 patients with metastatic breast cancer in the phase I clinic at MD Anderson: Prevalence and association with response.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.2606

Authors: Jennifer J. Wheler, Filip Janku, Johnique T. Atkins, Stacy L. Moulder, Ralph Zinner, J. Jack Lee, Gerald Steven Falchook, Apostolia Maria Tsimberidou, Sarina Anne Piha-Paul, Daniel D. Karp, Aung Naing, Siqing Fu, David S. Hong, Vivek Subbiah, Philip J. Stephens, Roman Yelensky, Vincent A. Miller, Vicente Valero, Razelle Kurzrock, Funda Meric-Bernstam

Institutions: The University of Texas MD Anderson Cancer Center, Foundation Medicine (United States), University of California San Diego, Moores Cancer Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2907138651

Cites:

Cited by:

Related to: 10